THYROCARE Stock Overview
Provides diagnostic testing services to patients, laboratories, and hospitals in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Thyrocare Technologies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹984.85 |
| 52 Week High | ₹1,003.55 |
| 52 Week Low | ₹535.05 |
| Beta | 0.44 |
| 11 Month Change | 11.67% |
| 3 Month Change | 11.31% |
| 1 Year Change | 83.71% |
| 33 Year Change | -12.61% |
| 5 Year Change | 76.20% |
| Change since IPO | 63.43% |
Recent News & Updates
Statutory Profit Doesn't Reflect How Good Thyrocare Technologies' (NSE:THYROCARE) Earnings Are
Oct 31
Recent updates
Statutory Profit Doesn't Reflect How Good Thyrocare Technologies' (NSE:THYROCARE) Earnings Are
Oct 31Thyrocare Technologies Limited (NSE:THYROCARE) Looks Just Right With A 26% Price Jump
Aug 01Thyrocare Technologies Limited (NSE:THYROCARE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Jul 26A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)
Jun 12Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult
Feb 29Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 04Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly
Dec 08Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 08Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively
Mar 23Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Mar 02Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First
Feb 01Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%
Jan 12
The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares
Dec 24Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive
Dec 17Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 30Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher
Nov 02Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates
Nov 01Shareholder Returns
| THYROCARE | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -0.1% | -2.3% | -3.4% |
| 1Y | 83.7% | 36.8% | 27.0% |
Return vs Industry: THYROCARE exceeded the Indian Healthcare industry which returned 38.5% over the past year.
Return vs Market: THYROCARE exceeded the Indian Market which returned 27.5% over the past year.
Price Volatility
| THYROCARE volatility | |
|---|---|
| THYROCARE Average Weekly Movement | 4.5% |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: THYROCARE has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: THYROCARE's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 1,693 | Rahul Guha | www.thyrocare.com |
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases.
Thyrocare Technologies Limited Fundamentals Summary
| THYROCARE fundamental statistics | |
|---|---|
| Market cap | ₹52.05b |
| Earnings (TTM) | ₹839.60m |
| Revenue (TTM) | ₹6.23b |
62.0x
P/E Ratio8.4x
P/S RatioIs THYROCARE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| THYROCARE income statement (TTM) | |
|---|---|
| Revenue | ₹6.23b |
| Cost of Revenue | ₹3.14b |
| Gross Profit | ₹3.09b |
| Other Expenses | ₹2.25b |
| Earnings | ₹839.60m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 15.86 |
| Gross Margin | 49.55% |
| Net Profit Margin | 13.47% |
| Debt/Equity Ratio | 0.02% |
How did THYROCARE perform over the long term?
See historical performance and comparison